Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16

Malignant melanoma is an aggressive cancer that develops drug resistance leading to poor prognosis. Efficient delivery of chemotherapeutic drugs to the tumor tissue remains a major challenge in treatment regimens. Using murine (B16) and human (SK-MEL-28) melanoma cells, we investigated traditional c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagwal, Sanjeev Kumar, Pasqual-Melo, Gabriella, Bodnar, Yana, Gandhirajan, Rajesh Kumar, Bekeschus, Sander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281583/
https://www.ncbi.nlm.nih.gov/pubmed/30518936
http://dx.doi.org/10.1038/s41419-018-1221-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281583/
https://www.ncbi.nlm.nih.gov/pubmed/30518936
http://dx.doi.org/10.1038/s41419-018-1221-6

Ejemplares similares